ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.22
0.03%
US Tech 100
19,287.60
-0.24%
S&P 500
5,702.55
-0.19%
US Dollar vs CAD
1.35815
-0.01%
Bitcoin
63,019.47
-0.29%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Allakos Inc (ALLK)

  7. Allakos Inc (ALLK) News

ALLK

Allakos (ALLK)

Allakos Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALLK
DateTimeSourceHeadlineSymbolCompany
09/12/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
09/11/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
09/11/20242:51PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
09/10/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
09/09/20243:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
09/06/20242:46PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
08/16/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALLKAllakos Inc
08/07/20243:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALLKAllakos Inc
08/07/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALLKAllakos Inc
08/07/20243:02PMGlobeNewswire Inc.Allakos Provides Business Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:ALLKAllakos Inc
06/25/20243:02PMGlobeNewswire Inc.Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety ProfileNASDAQ:ALLKAllakos Inc
06/10/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
06/10/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
06/07/20242:43PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
06/06/20243:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
05/29/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
05/29/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
05/29/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
05/28/20246:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALLKAllakos Inc
05/28/20246:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALLKAllakos Inc
05/28/20246:02AMGlobeNewswire Inc.Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous UrticariaNASDAQ:ALLKAllakos Inc
05/09/20244:09PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALLKAllakos Inc
05/09/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALLKAllakos Inc
05/09/20243:02PMGlobeNewswire Inc.Allakos Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:ALLKAllakos Inc
03/14/20243:02PMGlobeNewswire Inc.Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ALLKAllakos Inc
03/06/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
03/06/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
03/05/20243:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
03/04/20244:52PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
02/26/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALLKAllakos Inc
 Showing the most relevant articles for your search:NASDAQ:ALLK

Your Recent History

NASDAQ
AGBA
AGBA
NYSE
GME
GameStop
USOTC
MGON
Megola (PK)
USOTC
MWWC
Marketing Worldwide (PK)
USOTC
SINC
Sincerity Applied Materi... (PK)
USOTC
ICTY
Eyecity Com (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
ENZC
Enzolytics (PK)
USOTC
CBRF
CyberFuels (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
LEHNQ
Lehman Brothers Financial (CE)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
NASDAQ
DJT
Trump Media and Technology
NASDAQ
AVXL
Anavex Life Sciences
USOTC
MONI
Moon Equity (PK)
NASDAQ
FCEL
FuelCell Energy
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved